News from neurophage pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 14, 2014, 07:00 ET

NeuroPhage's GAIM Technology Chosen as 'Top Project to Watch' for the Therapeutic Area Partnerships Conference

NeuroPhage Pharmaceuticals, Inc., today announced that a panel of independent experts chose its lead project as one of the "Top Projects to Watch"...

Nov 04, 2014, 07:00 ET

NeuroPhage Appoints Industry Veteran Franz Hefti, PhD, President/COO

NeuroPhage Pharmaceuticals, Inc., a pioneering drug development company focused on diseases of protein misfolding, today announced the appointment...

Apr 22, 2014, 08:52 ET

NeuroPhage Discovers GAIM-changing Molecules to Combat Alzheimer's Disease and Other Neurodegenerative Disorders

 Researchers from NeuroPhage Pharmaceuticals, Inc. have engineered a series of molecules with the potential to treat most neurodegenerative...

Mar 25, 2014, 08:50 ET

NeuroPhage, Inc. Raises $17 Million In Series D Financing

NeuroPhage Pharmaceuticals, Inc. today announced the completion of a $17 million Series D financing from existing and new investors to advance the...

Dec 19, 2013, 09:15 ET

NeuroPhage Awarded Second Grant from Michael J. Fox Foundation for Parkinson's Disease Research

 NeuroPhage Pharmaceuticals, Inc. today announced that it has been awarded an $822,000 grant by The Michael J. Fox Foundation for Parkinson's...

Dec 03, 2013, 09:13 ET

NeuroPhage to Participate in World's First G8 Dementia Summit

 NeuroPhage Pharmaceuticals, Inc. today announced that it has been invited to participate in the world's first G8 Dementia Summit. The...

May 06, 2013, 07:30 ET

NeuroPhage, Inc. Raises $6.4 Million In Additional Financing

 NeuroPhage Pharmaceuticals, Inc., a company developing breakthrough therapies for neurodegenerative diseases, today announced that it raised...

Oct 17, 2012, 16:59 ET

NeuroPhage Reports Beneficial Effects of its Drug Candidate in a Pre-clinical Study of Parkinson's Disease Funded by The Michael J. Fox Foundation

 NeuroPhage Pharmaceuticals, Inc. announced today positive data with NPT001 in an alpha-synuclein pre-clinical model for Parkinson's disease...

Mar 08, 2012, 07:12 ET

NeuroPhage Extends Series B to $21.4M

 NeuroPhage Pharmaceuticals, Inc. (NeuroPhage), a privately held biotechnology company focused on a novel approach for disaggregating misfolded...

Feb 16, 2012, 10:12 ET

NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinson's Disease Research

 NeuroPhage Pharmaceuticals, Inc. announced today that it has been awarded funding by The Michael J. Fox Foundation (MJFF) to conduct...

Mar 01, 2011, 08:00 ET

NeuroPhage Pharmaceuticals Closes $12.4M Series B Round

NeuroPhage Pharmaceuticals, Inc. (NeuroPhage), a privately held biotechnology company developing a protein disaggregation platform for treatment of...